Inari Medical, Inc. (NARI) Tops Q4 EPS by 12c, Revenues Beat; Offers 1Q & FY21 Revenues Guidance Above Consensus
Go back to Inari Medical, Inc. (NARI) Tops Q4 EPS by 12c, Revenues Beat; Offers 1Q & FY21 Revenues Guidance Above Consensus| (NASDAQ: NARI) | Delayed: 79.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.97 | 52 Week High | $ | |||
| Open | $79.97 | 52 Week Low | $ | |||
| Day High | $79.97 | P/E | N/A | |||
| Day Low | $79.97 | EPS | $ | |||
| Volume | 3,000 | |||||

